Delivery Order SPE2DB20D3103-SPE2DB25FM2N1

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.37 firm fixed-price delivery order contract is for the supply of Humira (CF) Pen 40 mg/0.4 mL medication. The contract has an ultimate completion date of May 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of Humira(CF) Pen 40 mg/0.4 mls. The contract has a firm fixed price of $8,418.89 and a completion date of May 2, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a range of...
This federal contract award, with ID SPE2DB20D2200|SPE2DB24FX03W, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,309.34 firm fixed-price delivery order is for the supply of Humira (CF) Pen 40 mg/0.4 mL, a specialty medication used for various medical conditions. The contract has an ultimate completion date of August 29, 2024. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,930.78 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. The contract has an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,472.41 firm fixed-price delivery order is for Humira (CF) Pen 40 mg/0.4 mL, a specialty medication used for various medical conditions. The contract has a completion date of November 15, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,635.54 firm fixed-price delivery order is for HUMIRA(CF) PEN 40 MG/0.4 MLS and has a completion date of March 31, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a range of...
This federal contract award, with ID SPE2DB22D1103|SPE2DB25FTCF8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,173.43, is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty medication. This is a firm fixed-price delivery order contract with an ultimate completion date of November 27, 2024. The contract is not designated with a set-aside requirement,...
This federal contract award, with ID SPE2DB20D3505|SPE2DB23FU1G9, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,697.76 firm-fixed-price delivery order is for the supply of Humira (CF) Pen 40 mg/0.4 mL, a specialty medication. The contract has a completion date of May 16, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
This federal contract award SPE2DB20D3103|SPE2DB25FL3Q5, valued at $6,545.52, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialty pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of October 16, 2024. The contract does not have a set-aside designation,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Humira (CF) Pen 40 mg/0.4 mL. The contract, valued at $3,523.32, is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2N1
    Delivery Order

This federal contract award, with ID SPE2DB20D3103|SPE2DB25FM2N1, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,838.58, is for the delivery of Humira (CF) Pen 40 mg/0.4 mls. It is a firm fixed price delivery order contract with a completion date of January 9, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 4/9/25, 9:58 AM